Last reviewed · How we verify

NCT05980195

Cognitive Improvement After Carotid Stenting in Hyperbaric Oxygen Therapy Trial

Not yet recruiting NA Last updated 18 July 2024
What this trial tests

NA trial testing Hyperbaric oxygen therapy in Carotid Stenosis in 90 participants. Not yet recruiting.

Timeline
16 July 2024
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorBeijing Tiantan Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment90
Start date16 July 2024
Primary completion31 December 2025
Estimated completion31 December 2025

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tiantan Hospital

Who can join

Adults 18 to 75, any sex, with Carotid Stenosis or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of CARE-HBOT study is to evaluate whether patients with symptomatic severe carotid artery stenosis with cognitive impairment who underwent hyperbaric oxygen therapy plus standard medical treatment after stent implantation could improve their cognitive function compared with those who underwent standard postoperative medical treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Hyperbaric oxygen therapy

Trials testing the same drug.

Other recruiting trials for Carotid Stenosis

Currently open trials in the same condition.

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05980195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing